WALKME LTD (WKME)

IL0011765851 - Common Stock

13.95  0 (0%)

After market: 13.93 -0.02 (-0.14%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to WKME. WKME was compared to 281 industry peers in the Software industry. No worries on liquidiy or solvency for WKME as it has an excellent financial health rating, but there are worries on the profitability. WKME is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year WKME was profitable.
In the past year WKME had a positive cash flow from operations.
WKME had negative earnings in each of the past 5 years.
In the past 5 years WKME reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -9.47%, WKME is in line with its industry, outperforming 42.25% of the companies in the same industry.
Looking at the Return On Equity, with a value of -17.23%, WKME is in line with its industry, outperforming 45.77% of the companies in the same industry.
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WKME's Gross Margin of 85.25% is amongst the best of the industry. WKME outperforms 92.25% of its industry peers.
In the last couple of years the Gross Margin of WKME has grown nicely.
The Profit Margin and Operating Margin are not available for WKME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

WKME does not have a ROIC to compare to the WACC, probably because it is not profitable.
WKME has more shares outstanding than it did 1 year ago.
WKME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

WKME has an Altman-Z score of 2.93. This is not the best score and indicates that WKME is in the grey zone with still only limited risk for bankruptcy at the moment.
WKME's Altman-Z score of 2.93 is in line compared to the rest of the industry. WKME outperforms 53.87% of its industry peers.
WKME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.93
ROIC/WACCN/A
WACC9.55%

2.3 Liquidity

WKME has a Current Ratio of 2.04. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.04, WKME is in the better half of the industry, outperforming 61.97% of the companies in the same industry.
WKME has a Quick Ratio of 2.04. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
WKME's Quick ratio of 2.04 is fine compared to the rest of the industry. WKME outperforms 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 181.25% over the past year.
WKME shows a small growth in Revenue. In the last year, the Revenue has grown by 4.89%.
The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%

3.2 Future

WKME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.00% yearly.
WKME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.86% yearly.
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 53.65, WKME can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of WKME is on the same level as its industry peers.
WKME is valuated expensively when we compare the Price/Earnings ratio to 30.20, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 50.28, WKME can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as WKME.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, WKME is valued quite expensively.
Industry RankSector Rank
PE 53.65
Fwd PE 50.28

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of WKME indicates a somewhat cheap valuation: WKME is cheaper than 77.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.09
EV/EBITDA N/A

4.3 Compensation for Growth

WKME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WKME's earnings are expected to grow with 147.19% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y204.11%
EPS Next 3Y147.19%

0

5. Dividend

5.1 Amount

No dividends for WKME!.
Industry RankSector Rank
Dividend Yield N/A

WALKME LTD

NASDAQ:WKME (9/11/2024, 8:00:44 PM)

After market: 13.93 -0.02 (-0.14%)

13.95

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.30B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 85.25%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y643.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y